Translational therapeutics at the platelet vascular interface. Summary.
FitzGerald
Garret A
GA
Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, PA, USA. garret@spirit.gcrc.upenn.edu
D000789:Angina, Unstable / Q000188:drug therapy; D000818:Animals; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D000077144:Clopidogrel; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004502:Education, Medical, Continuing; D006801:Humans; D051379:Mice; D009203:Myocardial Infarction / Q000188:drug therapy / Q000517:prevention & control*; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D055502:Secondary Prevention; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin